WANG Zijun 1 , SHI Qianling 2 , GONG Enying 3 , LUO Xufei 1 , XUN Yangqin 3 , SHAO Ruitai 3 , CHEN Yaolong 1,4,5,6
  • 1. Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
  • 2. The First Clinical Medical College, Lanzhou University, Lanzhou 730000, P. R. China;
  • 3. School of Population Medicine and Public Health, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100052, P. R. China;
  • 4. Research Unit of Evidence-based Evaluation and Guidelines, Chinese Academy of Medical Sciences, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
  • 5. WHO Collaborating Centre for Guideline Implementation and Knowledge Translation, Lanzhou University, Lanzhou 730000, P. R. China;
  • 6. Institute of Health Data Science, Lanzhou University, Lanzhou 730000, P. R. China;
CHEN Yaolong, Email: chevidence@lzu.edu.cn
Multimorbidity; Clinical practice guideline; Guideline development
10.7507/1672-2531.202401171
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Multimorbidity is becoming a major issue in global health due to the increased prevalence of chronic diseases and the accelerated ageing of the population. Clinical practice guidelines, as a key tool for guiding clinical practice, play an important role in the field of multimorbidity, but also face many challenges. In this paper, we will review the necessity of developing multimorbidity guidelines, the current situation, challenges and opportunities, and on this basis, we will put forward our thoughts and suggestions to promote the development of guidelines in the field of multimorbidity in China.